1.Hair removal with intense pulsed light.
Meng-Hua HUO ; Guo-Zhang CHEN ; Li-Ying YAO
Chinese Journal of Plastic Surgery 2005;21(4):288-290
OBJECTIVETo evaluate the hair-removal effect of intense pulsed light (IPL).
METHODSThe unwanted hairs were removed with ELITE plus IPL. The treatment took 3 - 5 procedures, with an interval of over 2 months. 341 patients underwent the treatment.
RESULTSAll the patients were well tolerant without anesthesia. The unwanted hairs were wholly removed after 3 - 5 procedures. After operation, routine cleaning and make-up were allowed and bandaging was not necessary. There were blister in 3 cases and infection in 1 case. No pigmentation and scarring happened. Following-up of 3 - 6 months showed steady results with less regeneration of very thin and soft hair.
CONCLUSIONSIPL is an ideal hair-removal method because of the credible effect, simple operation, rapid treatment and no serious complications.
Adolescent ; Adult ; Child ; Female ; Hair Removal ; methods ; Humans ; Light ; Male ; Middle Aged ; Young Adult
2.Hair removal with intense pulsed light (IPL) for hairy skin grafts.
Meng-Hua HUO ; Li-Ying YAO ; Guo-Zhang CHEN
Chinese Journal of Plastic Surgery 2008;24(1):32-33
OBJECTIVETo evaluate the hair-removal effect of IPL for hairy skin grafts.
METHODS10 patients with hairy skin grafts were treated with IPL (ELITEplus) for hair removal 3 to 5 times at intervals of 2 months. The patients received IPL(610 - 1 000 nm) with spot size of 10 mm x 50 mm, pulse width of 5 msec with a delay of 2 - 20 msec, fluence of 30 - 38.3 J/cm2 .
RESULTSThe treatment was well tolerated with no need of anesthesia in all the patients. The hairs were removed completely after 3 to 5 treatments. The treated site could be washed as usual with no need of dressing. There was no blister, infection, hyperpigmentation and scarring. Only vellus were existed during the follow-up period of 6 - 12 months.
CONCLUSIONSIPL is a safe and reliable method to remove unwanted hair on skin grafts. It can be easily performed with a lower complication.
Adolescent ; Adult ; Burns ; surgery ; Female ; Hair Removal ; methods ; Humans ; Male ; Skin Transplantation ; methods ; Surgical Flaps ; Young Adult
3.Collagen changes of allografting an acellular dermal matrix.
Meng-hua HUO ; Ke-ming QI ; Jin-jing HUANG ; Zheng-yu GUAN ; Qiang ZHUANG ; Yang WANG ; Xiao-Yan LÜ
Chinese Journal of Plastic Surgery 2004;20(1):51-52
OBJECTIVETo evaluate the collagen changes of allografting an acellular dermal matrix (allo-ADM).
METHODSThe allo-ADM was grafted underneath the skin of SD rats. The content of collagen and the proportion of type I to III collagen was examined with a biochemical assay.
RESULTThe content of collagen and the proportion of type I to III collagen in the allo-ADM group showed no significant changes.
CONCLUSIONThe allo-ADM could keep long time in the body and it may be an ideal material for soft tissue filling.
Animals ; Collagen ; analysis ; Dermis ; metabolism ; transplantation ; Female ; Male ; Postoperative Period ; Rats ; Rats, Sprague-Dawley ; Skin Transplantation ; methods ; Transplantation, Homologous
4.Efficacy and safety of less invasive surfactant administration in the treatment of neonatal respiratory distress syndrome: a Meta analysis.
Meng-Yue HUO ; Hua MEI ; Yu-Heng ZHANG ; Chun-Zhi LIU ; Ya-Nan HU ; Dan SONG
Chinese Journal of Contemporary Pediatrics 2020;22(7):721-727
OBJECTIVE:
To evaluate the efficacy and safety of less invasive surfactant administration (LISA) in the treatment of neonatal respiratory distress syndrome (NRDS).
METHODS:
PubMed, Cochrane Library, Embase, China Biology Medicine disc, China Scientific Journal Database, CNKI Database, and Wanfang Database were searched for randomized controlled trials (RCTs) on the use of LISA strategy in the treatment of NRDS. Literature screening and quality assessment were performed according to inclusion and exclusion criteria. Review Manager 5.3 software was used to perform the Meta analysis.
RESULTS:
A total of 9 RCTs were included, with a total of 1 212 children with NRDS. There were 611 children in the experimental group (treated with LISA strategy) and 601 children in the control group [treated with intubation-surfactant-extubation (INSURE) strategy]. The Meta analysis showed that the use of LISA strategy reduced the rate of mechanical ventilation within 72 hours after birth (OR=0.39, 95%CI: 0.29-0.51, P<0.001) and the incidence rates of bronchopulmonary dysplasia (OR=0.53, 95%CI: 0.38-0.72, P<0.001) and pneumothorax (OR=0.56, 95%CI: 0.33-0.93, P=0.02). There were no significant differences in the mortality rate and incidence rates of other neonatal diseases between the two groups (P>0.05). There was no significant difference in the rate of repeated use of pulmonary surfactant (PS) between the two groups (P>0.05), but there was a higher incidence rate of PS reflux observed by LISA strategy (OR=2.60, 95%CI: 1.64-4.12, P<0.001).
CONCLUSIONS
Compared with INSURE strategy, LISA strategy has advantages in reducing the need for mechanical ventilation and the incidence rates of bronchopulmonary dysplasia and pneumothorax in children with NRDS.
China
;
Humans
;
Infant, Newborn
;
Infant, Premature
;
Pulmonary Surfactants
;
therapeutic use
;
Respiratory Distress Syndrome, Newborn
;
drug therapy
;
Surface-Active Agents
5.Analysis of measles immunity level in persistent populations in Beijing, 2012.
Juan LI ; Li LU ; Meng CHEN ; Fang HUANG ; Yang ZENG ; Xiao-mei LI ; Rui MA ; Jing-bin PAN ; Mu SUN ; Hao SUN ; Zhong-zhan WANG ; Fang-ru GUO ; Yi-hua ZHANG ; Feng-shuang WANG ; Tao WU ; De-jun CUI ; Xing-hui PENG ; Jiang WU ; Xing-huo PANG
Chinese Journal of Preventive Medicine 2013;47(10):916-919
OBJECTIVETo analyze the measles immunity level of persistent population in Beijing.
METHODSA total of 2125 objects from 10 age groups, who had been living in Beijing for over 6 months, were selected from urban and rural areas in Beijing in 2012. Demographic characteristics, history of measles and vaccine immunization were investigated by questionnaire. 5 ml blood sample of each subject was collected, and the Measles IgG antibody was measured by ELISA assay.
RESULTSPositive rate of measles antibody was 84.71% (1800/2125) and standardized positive rate was 88.07% . Median of antibody was 960.46 IU/L. Positive rate and median of measles antibody were significantly different between population from different age groups (χ(2) = 341.60, P < 0.01; H = 216.27, P < 0.01). Antibody positive rate and median were lowest in the <1 year age group, which were separately 43.06% (90/209) and 185.80 IU/L; and highest in the 1-4 (97.31% (181/186) and 2448.81 IU/L) and 5-9 years age group (96.46% (218/226) and 1910.72 IU/L). The range of antibody positive rate and median in adults of ≥ 15 years were 81.98%-90.14% and 744.38-1474.84 IU/L. Antibody positive rate and median in persistent population, which were separately 82.45% (883/1071) and 899.82 IU/L, were lower than those in migrant population, which were 87.00% (917/1054) and 166.19 IU/L, respectively (χ(2) = 8.51, P < 0.01;U = 538 704.00, P < 0.01). Antibody positive rate and median in population with vaccination history, which were separately 91.95% (891/969) and 1443.11 IU/L, were higher than those population without vaccination history and people whose history unknown (32.95% (57/173) , 127.33 IU/L; 86.67% (852/983) , 923.73 IU/L). The difference showed statistical significance (χ(2) = 399.92, P < 0.01; H = 202.11, P < 0.01).
CONCLUSIONAmong the persistent population in China, measles antibody level among the children aging 1-9 years old was high enough to prevent outbreak and epidemic of measles. However, we should try our best to strengthen the measles antibody level among the babies younger than 1 year old and the migrant population aging between 15 and 40 years old.
Adolescent ; Adult ; Antibodies, Viral ; blood ; Child ; Child, Preschool ; China ; epidemiology ; Female ; Humans ; Infant ; Male ; Measles ; epidemiology ; immunology ; prevention & control ; Measles virus ; Young Adult
6.An ambispective cohort study of the natural history of HIV infection among former unsafe commercial blood and plasma donors.
Fu-jie ZHANG ; Zhi-hui DOU ; Lan YU ; Ye MA ; Ning WANG ; Guang-hua CAO ; Chuan-tao LI ; Jin-xian ZHAO ; Xiang-dong MENG ; Xiao-chun QIAO ; Wei HUO ; Hong-xin ZHAO ; Zhong-fu LIU ; Lie WANG ; Hong SHANG
Chinese Journal of Epidemiology 2008;29(1):9-12
OBJECTIVEDiscussing the natural history and the influencing factors of HIV infection among former commercial blood and plasma donors engaged in unsafe blood donation practices in China.
METHODSUsing ambispective cohort study, with data obtained from ten counties (districts) from six provinces in the National AIDS Control Demonstration Area. HIV/AIDS cases were found and confirmed prior to July 24, 2006 being former commercial blood. Plasma donors were selected and data regarding infection, incidence, death, and influencing factors was collected. Analysis was performed using SPSS 12.0 statistical analysis software.
RESULTS(1) In 7551 cases of HIV infection, there were 6533 typical progressors (86.52%, 4757 cases of AIDS), 108 rapid progressors (1.43%), 910 long-term non-progressors (12.05%) with 4865 cases progressed to AIDS (64.43%). The median incubation period for HIV progression to AIDS was nine years (95% CI:8.96-9.04). (2) According to data, from a total of 1157 AIDS cases without ARV therapy (23.78% of total AIDS cases), there were 283 confirmed AIDS-related deaths, of which the median survival time was 6 months (95% CI:4-7) and the two and three year fatality rates were 95% and 99%, respectively. (3) The duration of HIV incubation period was irrespective to gender and age at the time of HIV infection (P > 0.05). Length of survival for untreated AIDS showed correlation to gender (P < 0.05) but no correlation with culture, marital status or age at the time of diagnosis of AIDS (P > 0.05).
CONCLUSIONCompared with the UNAIDS theory regarding slow disease progressors among adults, our study showed a longer AIDS incubation period and shorter outlook for untreated survival, but a similar incubation period for other routes of HIV infection.
Acquired Immunodeficiency Syndrome ; epidemiology ; mortality ; Adolescent ; Adult ; Aged ; Blood Donors ; statistics & numerical data ; China ; Female ; HIV Infections ; epidemiology ; mortality ; Humans ; Infectious Disease Incubation Period ; Male ; Middle Aged ; Young Adult
7.Investigation on measles cases of new genotype D8 in Beijing, 2013.
Juan LI ; Li LU ; Rui MA ; Meng CHEN ; Ai-hua LI ; Mu SUN ; Shu-fen SHI ; Yu-jun LU ; Zhong-zhan WANG ; Wen-wen MAO ; Ji-ye FU ; Tian-wei MA ; Hai-hong WANG ; Hai-tian SUI ; Li-ping ZHAO ; Yan-Tao XIE ; Fang HUANG ; Jiang WU ; Xing-huo PANG
Chinese Journal of Epidemiology 2013;34(11):1111-1114
OBJECTIVETo investigate the epidemiological characteristics of measles cases of new genotype D8 in Beijing from January to June, 2013.
METHODSEpidemiological survey and descriptive analysis was conducted.
RESULTS661 suspected measles were reported from January to June, 2013. 416 were confirmed measles cases by serology and etiology detection. 28 measles cases were caused by genotype D8 measles virus by genotype identification. There were 2 measles outbreak including 14 cases and 14 sporadic cases. The incidence peak was during April and May. 25 cases (89.3%, 25/28) occurred in downtown and suburban districts. 22 cases (78.5%, 22/28) were adults aged 15-39 years and 19 cases (67.9%, 19/28) were migrant population. 12 cases (85.7%, 12/14) in outbreak were migrant population working in clothing sales. There was epidemiological association between 2 outbreaks.
CONCLUSIONMeasles cases of genotype D8 were found for the first time in Beijing. Genotype D8 virus mainly infected migrant adults and caused local outbreak and endemic.
Adolescent ; Adult ; China ; epidemiology ; Disease Outbreaks ; Female ; Genotype ; Humans ; Incidence ; Male ; Measles ; epidemiology ; virology ; Measles virus ; genetics
8.Preparation of purified proteins from fresh Pheretima and their inhibitory effect against pulmonary fibrosis in mice.
Shu Yu LI ; Qi Xin YANG ; An Na ZUO ; Lin Hua TIAN ; Jin Hai HUO ; Yan Li MENG ; Qing Fa TANG ; Wei Ming WANG
Journal of Southern Medical University 2022;42(4):618-624
OBJECTIVE:
To develop a convenient method for rapid purification of fresh Pheretima proteins and assess the inhibitory effect of these proteins against pulmonary fibrosis.
METHODS:
The crude extract of fresh Pheretima was obtained by freeze-drying method and then purified by size exclusion chromatography. The composition of the purified proteins was analyzed by mass spectrometry. MRC-5 cells were treated with 5 ng/mL TGF-β1 alone (model group) or in combination with SB431542 (2 μmol/L) or the purified proteins (13.125 μg/mL), and the cytotoxicity of purified proteins and their inhibitory effects on cell proliferation were detected with CCK8 assay. Flow cytometry was used to detect the changes in cell apoptosis, and the cellular expressions of α-SMA, Vimentin, E-cadherin, collagen I, Smad2/3 and P-Smad2/3 were detected using RT-PCR and Western blotting. In the animal experiment, adult male C57BL/6 mice were subjected to intratracheal instillation of bleomycin followed by treatment with the purified proteins (5 mg/mL) for 21 days, after which HE and Masson staining was used to observe the pathological changes in the lung tissue of the mice.
RESULTS:
We successfully obtained purified proteins from fresh Pheretima protein by size exclusion chromatography. Treatment with the purified proteins significantly inhibited TGF-β1-induced proliferation of MRC-5 cells (P < 0.01), reduced the cellular expressions of α-SMA, Vimentin and collagen I (P < 0.001 or P < 0.01), increased the expression of E-cadherin (P < 0.01), and inhibited the expressions of Smad2/3 and P-Smad2/3 (P < 0.001 or P < 0.01). In male C57BL/6 mice models of bleomycin-induced pulmonary fibrosis, treatment with the purified proteins obviously reduced the number of inflammatory cells and fibrotic area in the lungs.
CONCLUSION
The purified proteins from fresh Pheretima obtained by size exclusion chromatography can inhibit pulmonary fibrosis in mice by regulating the TGF-β/ Smad pathway.
Animals
;
Biological Products/pharmacology*
;
Bleomycin/adverse effects*
;
Cadherins/metabolism*
;
Collagen Type I
;
Lung/pathology*
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Oligochaeta/chemistry*
;
Pulmonary Fibrosis/drug therapy*
;
Transforming Growth Factor beta1/metabolism*
;
Vimentin/metabolism*